US20220401452A1

Use of inhibitors of enhancer of zeste homolog 2

University of Texas System

Abstract

Described here are methods of assessing response of a patient to an EZH2 inhibitor and methods of treating certain cancers by administering therapeutically effective amounts of an EZH2 inhibitor and a PARP-1 inhibitor.

University: University of Texas System
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Kexin Xu
Priority date: June 26, 2019
Filing date: June 26, 2020
Publication date: December 22, 2022
Language: en
PDF source: https://patentimages.storage.googleapis.com/85/b4/33/13388c462379aa/US20220401452A1.pdf
Metadata fetched: August 29, 2026 00:29